Table 1.
Metabolite | Void | Total no. of urine samples | LOD (μg/L) | Detection frequency (%) | Percentile | ||||
---|---|---|---|---|---|---|---|---|---|
25th | 50th | 75th | 95th | 100th | |||||
Pyrethroid | |||||||||
PBA | First | 616 | 0.1 | 91 | 0.5 | 1.1 | 1.5 | 4.5 | 61.2 |
Last | 599 | 0.1 | 85 | 0.3 | 1.0 | 1.4 | 4.1 | 26.5 | |
4F3PBA | First | 599 | 0.2 | 16 | < LOD | < LOD | < LOD | 1.1 | 2.3 |
Last | 599 | 0.2 | 13 | < LOD | < LOD | < LOD | 1.0 | 61.2 | |
cis-DCCA | First | 599 | 0.2 | 37 | < LOD | < LOD | 0.7 | 1.7 | 46.0 |
Last | 599 | 0.2 | 32 | < LOD | < LOD | 0.4 | 1.3 | 4.6 | |
trans-DCCA | First | 599 | 0.4 | 55 | < LOD | 0.9 | 1.4 | 4.4 | 97.1 |
Last | 599 | 0.4 | 49 | < LOD | 0.6 | 1.3 | 3.9 | 27.7 | |
DBCA | First | 599 | 0.1 | 3 | < LOD | < LOD | < LOD | < LOD | 0.3 |
Last | 599 | 0.1 | 4 | < LOD | < LOD | < LOD | < LOD | 0.8 | |
OP | |||||||||
MDA | First | 616 | 0.3 | 57 | < LOD | 0.8 | 3.0 | 13.8 | 433.8 |
Last | 599 | 0.3 | 52 | < LOD | 0.6 | 3.2 | 16.9 | 283.8 | |
TCPy | First | 616 | 0.2 | 87 | 1.0 | 3.8 | 6.8 | 13.0 | 43.8 |
Last | 599 | 0.2 | 81 | 0.8 | 3.2 | 6.0 | 12.2 | 69.5 | |
IMPy | First | 600 | 0.7 | 3 | < LOD | < LOD | < LOD | < LOD | 16.2 |
Last | 586 | 0.7 | 4 | < LOD | < LOD | < LOD | < LOD | 31.4 | |
DEAMPy | First | 597 | 0.2 | 10 | < LOD | < LOD | < LOD | 0.6 | 26.7 |
Last | 593 | 0.2 | 18 | < LOD | < LOD | < LOD | 1.5 | 50.2 | |
Abbreviations: DBCA, cis-2,2-(dibromo)-2-dimethylvinyl-cyclopropane carboxylic acid; cis-DCCA, cis-2,2-(dichloro)-2-dimethylvinylcyclopropane carboxylic acid; trans-DCCA, trans-2,2-(dichloro)-2-dimethylvinylcyclopropane carboxylic acid; DEAMPy, 2-diethylamino-6-methyl-pyrmidin-4-ol; IMPy-2-isopropyl-4-methyl-6-hydroxypyrimidinol); MDA, malathion dicarboxylic acid; OP, organophosphorus; PBA, 3-phenoxybenzoic acid; 4F3PBA, 4-fluor-3-phenoxybenzoic acid; 3,5,6-trichloro-2-pyridinol; TCPy, 3,5,6-trichloro-2-pyridinol. |